A new study published in the Journal of American Medical Association showed that Type II cryoglobulinemic vasculitis was the ...

Basel: Novartis has announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag ...

Staying young might not be all it’s cracked up to be. While most people experience a decline in immune function with age, new ...